These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Invasive candidiasis in cancer patients: observations from a randomized clinical trial. DiNubile MJ, Hille D, Sable CA, Kartsonis NA. J Infect; 2005 Jun 19; 50(5):443-9. PubMed ID: 15907554 [Abstract] [Full Text] [Related]
6. Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy. Stam WB, Aversa F, Kumar RN, Jansen JP. Value Health; 2008 Jun 19; 11(5):830-41. PubMed ID: 18494752 [Abstract] [Full Text] [Related]
7. A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK. Bruynesteyn K, Gant V, McKenzie C, Pagliuca T, Poynton C, Kumar RN, Jansen JP. Eur J Haematol; 2007 Jun 19; 78(6):532-9. PubMed ID: 17419744 [Abstract] [Full Text] [Related]
8. Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK. Sidhu MK, van Engen AK, Kleintjens J, Schoeman O, Palazzo M. Curr Med Res Opin; 2009 Aug 19; 25(8):2049-59. PubMed ID: 19575628 [Abstract] [Full Text] [Related]
12. Caspofungin: a review of its use in the treatment of fungal infections. McCormack PL, Perry CM. Drugs; 2005 Sep 30; 65(14):2049-68. PubMed ID: 16162025 [Abstract] [Full Text] [Related]
13. Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany. Cornely OA, Sidhu M, Odeyemi I, van Engen AK, van der Waal JM, Schoeman O. Curr Med Res Opin; 2008 Jun 30; 24(6):1743-53. PubMed ID: 18477422 [Abstract] [Full Text] [Related]
15. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. Villanueva A, Arathoon EG, Gotuzzo E, Berman RS, DiNubile MJ, Sable CA. Clin Infect Dis; 2001 Nov 01; 33(9):1529-35. PubMed ID: 11588698 [Abstract] [Full Text] [Related]
19. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Olson JA, Adler-Moore JP, Smith PJ, Proffitt RT. Antimicrob Agents Chemother; 2005 Dec 01; 49(12):4895-902. PubMed ID: 16304150 [Abstract] [Full Text] [Related]
20. Economic evaluation of micafungin vs. liposomal amphotericin B (LAmB) for the treatment of candidaemia and invasive candidiasis (IC). Neoh CF, Liew D, Slavin MA, Marriott D, Chen SC, Morrissey O, Stewart K, Kong DC. Mycoses; 2013 Sep 01; 56(5):532-42. PubMed ID: 23496163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]